Most Ph+ ALL and BC CML carried the highly TKI-resistant gatekeeper T315I BCR-ABL1 kinase domain mutation, while all CP CML samples were BCR-ABL1 wild type. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.